bioRxivCell BiologyPreprint
Decreasing ELK3 expression improves Bone Morphogenetic Protein Receptor 2 signaling and pulmonary vascular cell function in PAH
M. K. Ali, L. Zhao, V. A. d. J. Perez, M. R. Nicolls, E. Spiekerkoetter
Abstract
ELK3 is upregulated in blood and pulmonary vascular cells of PAH patients and may play a significant role in PAH potentially through modulating BMPR2 signaling.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Paracrine Action of Bone Morphogenetic Protein 3 in Pulmonary Arterial Hypertension
Aymen Halouani, Eric Mensiah, … Yassine Sassi·European Respiratory JournalPeer-reviewed·Jul 30, 2026
- PTPN1 deficiency modulates BMPR2 signaling and induces endothelial dysfunction in Pulmonary Arterial Hypertension
M. K. Ali, X. Tian, … E. Spiekerkoetter·bioRxiv·Nov 27, 2022
- Endothelial β3-Adrenergic Receptor activation prevents pulmonary hypertension
Silvia Faria da Rocha, Laura de la Bastida-Casero, … Eduardo Oliver·bioRxiv·Jul 20, 2026
- BMP9 regulates the endothelial secretome to drive pulmonary hypertension
Ying Zhong, Peiran B Yang, … Paul B. Yu·bioRxiv·Aug 29, 2025
- Targeting IL-6-STAT3/STAT4 Signaling Restores FOXP3 Expression in Pulmonary Arterial Endothelium and Reveals Novel Biomarkers for PAH
Prabhjot Kaur, Katherine Jankowski, … Lahouaria Hadri·bioRxiv·May 2, 2026
- Epigenetic Activation of Endothelial Smurf1 via EP300-Mediated H3K27ac Disrupts BMPR2 Signaling in Pulmonary Arterial Hypertension
Celine Leppert, Marîa Teresa Ochoa, … Malik Bisserier·bioRxiv·Oct 30, 2025